Erin M. Wessling, Executive Vice President and Chief Legal Officer of Elevance Health, Inc., filed a Form 4 on September 4, 2026, disclosing two transactions involving the withholding of common shares to cover tax liabilities upon the vesting of previously granted restricted stock.

Key Highlights

  • Reporting person: Erin M. Wessling, EVP and Chief Legal Officer of Elevance Health, Inc. (NYSE:ELV)
  • First transaction: 94 shares of common stock disposed of on 09/02/2026 at $405.84 per share via transaction code F
  • Second transaction: 255 shares of common stock disposed of on 09/03/2026 at $414.78 per share via transaction code F
  • Purpose: Both disposals were for payment of tax liability by withholding stock incident to the vesting of previously granted restricted stock
  • Resulting ownership: 7,230 shares of common stock held directly following the reported transactions

Wessling's Restricted Stock Vesting and Tax Withholding Transactions at Elevance Health

According to the filing, Erin M. Wessling, identified as EVP and Chief Legal Officer of Elevance Health, Inc., reported two disposals of common stock occurring on consecutive days in September 2026. Both transactions carried transaction code F, which corresponds to shares withheld by the issuer for tax purposes in connection with equity award vesting.

The first disposal, dated 09/02/2026, involved 94 shares at a price of $405.84, reducing her directly held position to 7,485 shares. The second disposal, dated 09/03/2026, involved 255 shares at a price of $414.78, further reducing her directly held position to 7,230 shares. The filing's footnote states that both disposals represent "payment of tax liability by withholding stock incident to the vesting of previously granted restricted stock." No derivative securities were reported in Table II of the filing.

The Form 4 was signed by Kathleen S. Kiefer as attorney in fact on 09/04/2026. The filing indicates that Wessling filed as a single reporting person and that all shares reported are held directly.

What Was Disclosed

Elevance Health EVP and Chief Legal Officer Erin M. Wessling disclosed two share disposals totaling 349 shares between 09/02/2026 and 09/03/2026, both attributed to tax withholding on restricted stock vesting, leaving her with 7,230 directly held shares.